Exagen Increases FY24 Revenue Outlook To At Least $57M Vs Prior Outlook Of At Least $55M; Estimate $55.75M
Portfolio Pulse from Benzinga Newsdesk
Exagen Inc. has increased its FY24 revenue outlook to at least $57 million, up from the previous outlook of at least $55 million. The company also expects its adjusted EBITDA loss to be better than $12 million, an improvement from the prior outlook of better than negative $18 million.
August 05, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exagen Inc. has raised its FY24 revenue outlook to at least $57 million and expects a smaller adjusted EBITDA loss of better than $12 million.
The increase in revenue outlook and improved EBITDA loss projection are positive indicators of Exagen's financial health and operational performance. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100